-
Mashup Score: 7The RECOVER IV Trial - Full Text View - ClinicalTrials.gov - 20 day(s) ago
The RECOVER IV Trial – Full Text View.
Source: classic.clinicaltrials.govCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 15Impact of Interventricular Interaction on Ventricular Function: Insights From Right Ventricular Pressure-Volume Analysis - 24 day(s) ago
Abstract Background Interventricular interactions may be responsible for the decline in ventricular performance observed in various disease states that primarily affect the contralateral ventricle….
Source: www.jacc.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 13Impact of Interventricular Interaction on Ventricular Function: Insights From Right Ventricular Pressure-Volume Analysis - 26 day(s) ago
Abstract Background Interventricular interactions may be responsible for the decline in ventricular performance observed in various disease states that primarily affect the contralateral ventricle….
Source: www.jacc.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 3
Cardiogenic shock (CS) is a time-sensitive and hemodynamically complex syndrome with a broad spectrum of etiologies and clinical presentations. Despite contemporary therapies, CS continues to maintain high morbidity and mortality ranging from 35 to 50%. More recently, burgeoning observational research in this field aimed at enhancing the early recognition and characterization of the shock state through standardized team-based protocols, comprehensive hemodynamic profiling, and tailored and selective utilization of temporary mechanical circulatory support devices has been associated with improved outcomes. In this narrative review, we discuss the pathophysiology of CS, novel phenotypes, evolving definitions and staging systems, currently available pharmacologic and device-based therapies, standardized, team-based management protocols, and regionalized systems-of-care aimed at improving shock outcomes. We also explore opportunities for fertile investigation through randomized and non-ran
Source: www.frontiersin.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 3
Cardiogenic shock (CS) is a time-sensitive and hemodynamically complex syndrome with a broad spectrum of etiologies and clinical presentations. Despite contemporary therapies, CS continues to maintain high morbidity and mortality ranging from 35 to 50%. More recently, burgeoning observational research in this field aimed at enhancing the early recognition and characterization of the shock state through standardized team-based protocols, comprehensive hemodynamic profiling, and tailored and selective utilization of temporary mechanical circulatory support devices has been associated with improved outcomes. In this narrative review, we discuss the pathophysiology of CS, novel phenotypes, evolving definitions and staging systems, currently available pharmacologic and device-based therapies, standardized, team-based management protocols, and regionalized systems-of-care aimed at improving shock outcomes. We also explore opportunities for fertile investigation through randomized and non-ran
Source: www.frontiersin.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 15- YouTube - 1 month(s) ago
Enjoy the videos and music you love, upload original content, and share it all with friends, family, and the world on YouTube.
Source: www.youtube.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 2Research Priorities in Critical Care Cardiology: JACC Expert Panel - 2 month(s) ago
Abstract Over the last several decades, the cardiac intensive care unit (CICU) has seen a substantial evolution in the patient population, comorbidities, and diagnoses. However, the generation of h…
Source: www.jacc.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 70All That Raises Lactate Is Not Sepsis - 4 month(s) ago
A 43-year-old woman with asthma presented with chest tightness and dyspnea despite albuterol use. She was alert, normotensive, and tachypneic. Arterial blood gas measurement with the patient breathing air demonstrated a pH of 7.32; a carbon dioxide tension/partial pressure measurement, P CO 2, of 35 mm Hg; an oxygen tension/partial pressure measurement, P o 2, of 76 mm Hg; HCO 3 − at 18 mEq/L; and lactate at 2.6 mmol/L. After continuous nebulized albuterol and 3 L crystalloid, her serum lactate increased
Source: www.atsjournals.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 70All That Raises Lactate Is Not Sepsis - 4 month(s) ago
A 43-year-old woman with asthma presented with chest tightness and dyspnea despite albuterol use. She was alert, normotensive, and tachypneic. Arterial blood gas measurement with the patient breathing air demonstrated a pH of 7.32; a carbon dioxide tension/partial pressure measurement, P CO 2, of 35 mm Hg; an oxygen tension/partial pressure measurement, P o 2, of 76 mm Hg; HCO 3 − at 18 mEq/L; and lactate at 2.6 mmol/L. After continuous nebulized albuterol and 3 L crystalloid, her serum lactate increased
Source: www.atsjournals.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 20
Heart failure (HF) remains a major cause of morbidity and mortality worldwide. Major advancements in optimal guideline-directed medical therapy, including novel pharmacological agents, are now available for the treatment of chronic HF including HF with reduced ejection fraction and HF with preserved ejection fraction. Despite these efforts, there are several limitations of medical therapy including but not limited to: delays in implementation and/or initiation; inability to achieve target dosing; tolerability; adherence; and recurrent and chronic costs of care.
Source: www.jscai.orgCategories: General Medicine News, CardiologistsTweet
@Nikhil15 @NavinKapur4 @manreetkanwar @JHMontfort10 @ReshadGaranMD @BurkhoffMd @JasonKatzMD Great points, Nikhil! Recover IV now underway. Will you enroll and randomize? https://t.co/2EimdF4Xob